Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SVC112
i
Other names:
SVC112
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
SuviCa
Drug class:
Protein synthesis inhibitor
Related drugs:
‹
MT-5111 (4)
omacetaxine mepesuccinate (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
LCB01-0371 (1)
Imtox19/Imtox22 (0)
MT-3724 (0)
OXS-1550 (0)
oportuzumab monatox (0)
minocycline (0)
RSO-021 (0)
MT-5111 (4)
omacetaxine mepesuccinate (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
LCB01-0371 (1)
Imtox19/Imtox22 (0)
MT-3724 (0)
OXS-1550 (0)
oportuzumab monatox (0)
minocycline (0)
RSO-021 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login